BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26047578)

  • 21. The detection and clinical significance of peripheral regulatory CD4
    Qiu J; Che G; Liu F; Sha X; Ju S; Ma H; Feng L
    Clin Transl Oncol; 2019 Oct; 21(10):1343-1347. PubMed ID: 30788838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.
    Kurose K; Ohue Y; Wada H; Iida S; Ishida T; Kojima T; Doi T; Suzuki S; Isobe M; Funakoshi T; Kakimi K; Nishikawa H; Udono H; Oka M; Ueda R; Nakayama E
    Clin Cancer Res; 2015 Oct; 21(19):4327-36. PubMed ID: 26429981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer.
    Shen L; Zhang LL; Li H; Liu X; Yu XX; Hu P; Hui H; Guo QL; Zhang S
    Oncotarget; 2017 Jul; 8(30):49395-49408. PubMed ID: 28472762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulated TIGIT
    Lin F; Hu X; Zhang Y; Ye S; Gu Y; Yan B; Wang L; Jiang Y
    Mol Immunol; 2022 Jul; 147():40-49. PubMed ID: 35504057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
    Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study.
    Zhao T; Yang C; Qiu Y; Xue Y; Zhao Z; Song D; Qiu Y; Ma Z; Yang B; Xu M; Rong R; Zhu T
    Transplant Proc; 2013; 45(1):148-52. PubMed ID: 23375289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD).
    Tan DB; Fernandez S; Price P; French MA; Thompson PJ; Moodley YP
    Immunobiology; 2014 Dec; 219(12):975-9. PubMed ID: 25097153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive properties of regulatory T cells generated by incubation of peripheral blood mononuclear cells with supernatants of human RPE cells.
    Imai A; Sugita S; Kawazoe Y; Horie S; Yamada Y; Keino H; Maruyama K; Mochizuki M
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7299-309. PubMed ID: 23036994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients.
    Germain C; Devi-Marulkar P; Knockaert S; Biton J; Kaplon H; Letaïef L; Goc J; Seguin-Givelet A; Gossot D; Girard N; Validire P; Lefèvre M; Damotte D; Alifano M; Lemoine FM; Steele KE; Teillaud JL; Hammond SA; Dieu-Nosjean MC
    Front Immunol; 2021; 12():626776. PubMed ID: 33763071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.
    Kotsakis A; Koinis F; Katsarou A; Gioulbasani M; Aggouraki D; Kentepozidis N; Georgoulias V; Vetsika EK
    Sci Rep; 2016 Dec; 6():39247. PubMed ID: 27976733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile.
    Prado-Garcia H; Romero-Garcia S; Rumbo-Nava U; Lopez-Gonzalez JS
    Anticancer Res; 2015 Mar; 35(3):1529-35. PubMed ID: 25750307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer.
    Yukawa T; Shimizu K; Maeda A; Yasuda K; Saisho S; Okita R; Nakata M
    Oncol Rep; 2015 Jan; 33(1):74-80. PubMed ID: 25338928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
    Zhang M; Zhou J; Zhao T; Huang G; Tan Y; Tan S; Fu X; Niu W; Meng G; Chen X; Shang X; Liu D; Ni B; Wang L; Wu Y
    J Infect Dis; 2012 Apr; 205(7):1111-20. PubMed ID: 22357657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of immunoregulatory T cells in different stages of breast cancer patients.
    Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
    Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.
    Zhao S; Jiang T; Zhang L; Yang H; Liu X; Jia Y; Zhou C
    Oncotarget; 2016 Jun; 7(24):36065-36073. PubMed ID: 27153545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.